Address
Email address
Phone number
Website
Name
DAB Eesti OÜ
Registry code
11149461
VAT number
EE100977619
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
27.06.2005 (19)
Financial year
01.01-31.12
Capital
95 931.00 €
Activity
4646 - Wholesale of pharmaceutical goods
2 140 629 €
190 828 €
9%
-
1 166 039 €
7
Submitted
No tax arrears
16%
15%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Agnė Bagdžiūnaitė 28.04.1977 (47) | - | Board member | - | |
| Veiko Hintsov 10.02.1969 (55) | - | - | - | Auditor who has assessed non-monetary contribution |
| Aktsiaselts SIROWA TALLINN 10634036 | - | - | - | Founder |
| 2019 31.03.2020 | 2020 19.03.2021 | 2021 29.05.2022 | 2022 20.03.2023 | 2023 26.03.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 2 809 654 € | 2 564 500 € | 2 563 173 € | 2 437 723 € | 2 140 629 € |
| Net profit (loss) for the period | 210 252 € | 177 141 € | 212 983 € | 201 203 € | 190 828 € |
| Profit Margin | 7% | 7% | 8% | 8% | 9% |
| Current Assets | 1 303 389 € | 1 201 683 € | 1 236 937 € | 1 255 846 € | 1 237 267 € |
| Fixed Assets | 44 176 € | 33 099 € | 72 935 € | 49 938 € | 36 071 € |
| Total Assets | 1 347 565 € | 1 234 782 € | 1 309 872 € | 1 305 784 € | 1 273 338 € |
| Current Liabilities | 251 299 € | 171 627 € | 184 057 € | 157 538 € | 107 299 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 1 096 266 € | 1 063 155 € | 1 125 815 € | 1 148 246 € | 1 166 039 € |
| Employees | 7 | 6 | 7 | 7 | 7 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 607 831.74 € | 88 554.9 € | 27 634.45 € | 6 |
| 2023 Q4 | 837 049.31 € | 118 112.17 € | 27 097.83 € | 7 |
| 2023 Q3 | 820 502.74 € | 105 179.49 € | 26 525.85 € | 6 |
| 2023 Q2 | 973 137.28 € | 156 703.71 € | 27 931.22 € | 7 |
| 2023 Q1 | 877 400.73 € | 109 449.13 € | 27 038.08 € | 7 |
| 2022 Q4 | 989 183.34 € | 125 016.98 € | 23 623.15 € | 7 |
| 2022 Q3 | 881 502.44 € | 105 795.56 € | 21 866.39 € | 7 |
| 2022 Q2 | 1 132 574.06 € | 157 646.35 € | 24 270.65 € | 5 |
| 2022 Q1 | 1 041 389.78 € | 128 545.22 € | 30 262.26 € | 6 |
| 2021 Q4 | 1 123 579.73 € | 125 293.86 € | 23 388.97 € | 8 |
| 2021 Q3 | 880 312.7 € | 102 067.28 € | 27 618.92 € | 7 |
| 2021 Q2 | 1 149 595.82 € | 163 151.88 € | 24 492.95 € | 7 |
| 2021 Q1 | 1 051 014.32 € | 116 319.88 € | 26 133.64 € | 7 |
| 2020 Q4 | 1 183 115.59 € | 152 863.51 € | 25 437.83 € | 7 |
| 2020 Q3 | 1 034 382.52 € | 167 035.59 € | 17 474.89 € | 6 |
| 2020 Q2 | 612 667.26 € | 86 161.85 € | 25 537.94 € | 6 |
| 2020 Q1 | 1 177 381.32 € | 137 937.96 € | 29 704.41 € | 6 |
